Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3915289
Max Phase: Preclinical
Molecular Formula: C37H38N6O5S3
Molecular Weight: 742.95
Molecule Type: Small molecule
Associated Items:
ID: ALA3915289
Max Phase: Preclinical
Molecular Formula: C37H38N6O5S3
Molecular Weight: 742.95
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)CN(C(CO)c1ccc(CNC(=O)C(NC(=O)c2ccccc2)C(c2ccccc2)c2cn[nH]c2)s1)S(=O)(=O)c1ccc2ncsc2c1
Standard InChI: InChI=1S/C37H38N6O5S3/c1-24(2)21-43(51(47,48)29-14-15-30-33(17-29)49-23-39-30)31(22-44)32-16-13-28(50-32)20-38-37(46)35(42-36(45)26-11-7-4-8-12-26)34(27-18-40-41-19-27)25-9-5-3-6-10-25/h3-19,23-24,31,34-35,44H,20-22H2,1-2H3,(H,38,46)(H,40,41)(H,42,45)
Standard InChI Key: MPVYFSLVZYPUMQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 742.95 | Molecular Weight (Monoisotopic): 742.2066 | AlogP: 5.71 | #Rotatable Bonds: 15 |
Polar Surface Area: 157.38 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 13.15 | CX Basic pKa: 2.45 | CX LogP: 5.27 | CX LogD: 5.27 |
Aromatic Rings: 6 | Heavy Atoms: 51 | QED Weighted: 0.11 | Np Likeness Score: -1.41 |
1. (2015) HIV protease inhibitors, |
Source(1):